...
首页> 外文期刊>Molecular pharmaceutics >Intestinal Permeability Study of Minoxidil: Assessment of Minoxidil as a High Permeability Reference Drug for Biopharmaceutics Classification
【24h】

Intestinal Permeability Study of Minoxidil: Assessment of Minoxidil as a High Permeability Reference Drug for Biopharmaceutics Classification

机译:米诺地尔的肠渗透性研究:米诺地尔作为生物药物分类中高渗透性参考药物的评估

获取原文
获取原文并翻译 | 示例
           

摘要

The purpose of this study was to evaluate minoxidil as a high permeability reference drug for Biopharmaceutics Classification System (BCS). The permeability of minoxidil was determined in in situ intestinal perfusion studies in rodents and permeability studies across Caco-2 cell monolayers. The permeability of minoxidil was compared with that of metoprolol, an FDA reference drug for BCS classification. In rat perfusion studies, the permeability of minoxidil was somewhat higher than that of metoprolol in the jejunum, while minoxidil showed lower permeability than metoprolol in the ileum. The permeability of minoxidil was independent of intestinal segment, while the permeability of metoprolol was region-dependent. Similarly, in mouse perfusion study, the jejunal permeability of minoxidil was 2.5-fold higher than that of metoprolol. Minoxidil and metoprolol showed similar permeability in Caco-2 study at apical pH of 6.5 and basolateral pH of 7.4. The permeability of minoxidil was independent of pH, while metoprolol showed pH-dependent transport in Caco-2 study. Minoxidil exhibited similar permeability in the absorptive direction (AP-BL) in comparison with secretory direction (BL-AP), while metoprolol had higher efflux ratio (ER > 2) at apical pH of 6.5 and basolateral pH of 7.4. No concentration-dependent transport was observed for either minoxidil or metoprolol transport in Caco-2 study. Verapamil did not alter the transport of either compounds across Caco-2 cell monolayers. The permeability of minoxidil was independent of both pH and intestinal segment in intestinal perfusion studies and Caco-2 studies. Caco-2 studies also showed no involvement of carrier mediated transport in the absorption process of minoxidil. These results suggest that minoxidil may be an acceptable reference drug for BCS high permeability classification. However, minoxidil exhibited higher jejunal permeability than metoprolol and thus to use minoxidil as a reference drug would raise the permeability criteria for BCS high permeability classification.
机译:这项研究的目的是评估米诺地尔作为生物制药分类系统(BCS)的高渗透性参考药物。米诺地尔的渗透性是在啮齿类动物的原位肠灌注研究中确定的,并在整个Caco-2细胞单层中进行了渗透性研究。将米诺地尔的通透性与美托洛尔的通透性进行比较,美托洛尔是用于BCS分类的FDA参考药物。在大鼠灌注研究中,米诺地尔在空肠中的通透性略高于美托洛尔,而米诺地尔则比回肠中的美托洛尔低。米诺地尔的通透性与肠段无关,而美托洛尔的通透性是区域依赖性的。同样,在小鼠灌注研究中,米诺地尔的空肠通透性比美托洛尔高2.5倍。在Caco-2研究中,米诺地尔和美托洛尔在心尖pH 6.5和基底外侧pH 7.4时显示出相似的渗透性。在Caco-2研究中,米诺地尔的渗透性与pH无关,而美托洛尔则显示pH依赖的转运。与分泌方向(BL-AP)相比,米诺地尔在吸收方向(AP-BL)上表现出相似的渗透性,而美托洛尔在顶端pH 6.5和基底外侧pH 7.4时具有更高的流出比(ER> 2)。在Caco-2研究中,未观察到米诺地尔或美托洛尔的浓度依赖性转运。维拉帕米不改变任何一种化合物跨Caco-2细胞单层的转运。在肠灌注研究和Caco-2研究中,米诺地尔的渗透性与pH和肠段均无关。 Caco-2研究还显示,米诺地尔的吸收过程中不涉及载体介导的转运。这些结果表明米诺地尔可能是BCS高渗透性分类的可接受参考药物。但是,米诺地尔的空肠通透性高于美托洛尔,因此使用米诺地尔作为参考药物将提高BCS高通透性分类的通透性标准。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号